Study of Nasal Insulin to Fight Forgetfulness - Device Study
Status:
Active, not recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The SNIFF Device study will involve using a device to administer insulin through each
participant's nose or intra-nasally. Insulin is a hormone that is produced in the body. It
works by lowering levels of glucose (sugar) in the blood. This study is measuring how much
insulin the device delivers. In addition, this study will look at the effects of insulin or
placebo administered intra-nasally using a nebulizer-like device on memory, blood, and
cerebral spinal fluid.
Phase:
Phase 2
Details
Lead Sponsor:
Suzanne Craft Wake Forest University Health Sciences